Use of Raman spectroscopy to evaluate the biochemical composition of normal and tumoral human brain tissues for diagnosis

Raman spectroscopy is used to identify the biochemical differences between normal brain tissue (cerebellum and meninges) compared with tumor (glioblastoma, medulloblastoma, schwannoma and meningioma) through biochemical information obtained from the sample.

A total of 263 spectra were obtained from fragments of cerebellum normal (65), meninges normal (69), glioblastoma (28), schwannoma (8), medulloblastoma (19), and meningioma (74), which is collected using dispersive the Raman spectrometer ( 830 nm, near infrared power, output 350 mW, 20 s exposure time to obtain the spectrum), coupled to the Raman probe.

A model spectral based quadratic fit was developed to estimate the concentration of biochemistry of 16 biochemical compounds present in brain tissue, among them the most characterized the spectrum of brain tissue, such as linolenic acid, triolein, cholesterol, sphingomyelin, phosphatidylcholine, β-carotene, collagen, phenylalanine, DNA, glucose, and blood.

Of biochemical information, classification spectra in normal and tumor groups was performed according to the type of brain tumor and corresponding normal tissue. The classifications used in the model of discrimination is (a) the concentration of the biochemical constituents of the brain, through a linear discriminant analysis (LDA), and (b) the spectrum of the network, through discrimination by partial least squares (PLS-DA) regression.

The model obtained 93.3% accuracy with LDA discrimination between normal and tumor cerebellum groups separated according to the concentration of biochemical constituents and 94.1% in discrimination by PLS-DA using the whole spectrum. The results obtained showed that the Raman technique is a promising tool for distinguishing concentrations of biochemical compounds present in brain tissue, both normal and tumor. The concentration predicted by models of biochemical and all information contained in Raman spectra were both able to classify pathologic group.

Persistence biochemistry of prostate specific antigen after robot-assisted Laparoscopic Radical Prostatectomy: Tumor localization using PSMA PET / CT imaging

Since the introduction of radiolabeled prostate-specific membrane antigen (PSMA) positron emission tomography / computed tomography (PET / CT), the ability to visualize recurrent prostate cancer has increased substantially. However, PSMA radiolabeled diagnostic accuracy of PET / CT in patients with biochemical persistence (BCP; ie, continuously measured prostate-specific antigen (PSA) -values ​​after robot-assisted laparoscopic radical prostatectomy (RARP)) largely lacking.

Therefore, the aim of this study was to determine the role of PSMA (ie, 18F-DCFPyL or 68Ga-PSMA-11) PET / CT imaging in patients with BCP after RARP and to evaluate the site of disease are persistent on PSMA PET / CT. Methods: A total of 150 consecutive patients with BCP after undergoing RARP PSMA radiolabeled PET / CT imaging were retrospectively evaluated. BCP is defined as any first detectable serum PSA values ​​after RARP (≥0.1 ng / mL) for at least 6 weeks after surgery, the absence of an undetectable PSA values ​​after RARP.

A multivariable logistic regression analysis was performed to identify predictors for the detection of metastases outside the prostate fossa (≥miN1) on PSMA PET / CT. Results: A PSMA PET / CT was performed in the PSA-median value of 0.60 ng / mL (interquartile range (IQR) from 0.3 to 2.4) after a median period of 6 months (IQR 4-10) following RARP. In total, 101/150 patients (67%) had lesions with PSMA-expression PET / CT, which was 89/150 patients (59%) had lesions with increased expression of PSMA sites outside the prostatic fossa.

Fermentation optimization, purification and biochemical characterization of ι-carrageenase of marine bacteria Cellulophaga Baltica

Degrading marine bacterium ι-carrageenan, Cellulophaga Baltica, isolated from the surface of red algae filaments fucoides Vertebrates. ι-carrageenase maximum production is optimized by single factor experiment. The optimum fermentation conditions was 1.6 g / L furcellaran, 4 g / L of yeast extract as a carbon source, 5 g / L sea salt, and 48 hours of incubation at 20 ° C. Extracellular ι-carrageenase of culture supernatant purified by ultrafiltration , ammonium sulfate precipitation, and finally with anion exchange chromatography, showing 26 fold increase in specific activity compared to that in the crude enzyme.

According to the results of SDS-PAGE and HPLC-SEC, estimated molecular weight of 31 kDa purified enzyme. Purified enzyme showed maximum specific activity of 571 U / mg at 40 ° C and pH 7.5 to 8.0. It retains 73% of the total activity below 40 ° C and 90% of total activity at pH 7.2.

Especially, the enzyme is ι-carrageenase cold-adapted, which showed 33.4% of the maximum activity at 10 ° C. The enzyme is stimulated by Na +, K +, and NH4 +, while Ca 2+, Mg 2+, Fe 3+, sea salt and EDTA acts as an inhibitor of the enzyme.

Effect of Ramadan intermittent fasting on cognitive responses, physical and biochemical for heavy short-term exercise in young female elite handball players

This study aims to assess the effects of intermittent fasting Ramadan (RF) in response to cognitive, physical and biochemistry to exercise in young female elite handball players. Twelve athletes participated in three experimental sessions: one week before Ramadan (BR), in the first week of Ramadan (FWR) and during the last week of Ramadan (LWR).

Crossover studies carried out in Tunisia during the 2013 Ramadan which takes place from 9 July to 7 August. During each session, a battery test is performed as follows: Index Hooper, tests alertness (VT), Epworth sleepiness scale (ESS), five test jump (5-JT), modified agility T-test (MAT), the maximum stood ball speed test – throw (MSBVT) and Running-based Anaerobic Sprint (RAST) test. Ratings of perceived exertion (RPE) was recorded immediately after the RAST.

Blood samples were taken before and after exercise during each session. The results showed that the higher the ESS score for LWR of BR (p <0.05). In addition, MSBVT time decreased (p <0.05) for LWR, because it improved performance. Strength three final sprint of RAST decreased significantly only for LWR compared with BR (p <0.05). RAST fatigue index and higher RPE scores for LWR more than BR (p <0.05).

The results showed also measures hematology (blood cell, namely, red, hemoglobin, and hematocrit), plasma osmolarity and energetic markers are not affected by RF. Biomarkers higher muscle damage after RAST only for LWR compared with BR (p <0.01 for all). In conclusion, increased RF performance decline RAST ESS and associated with higher muscle damage and fatigue, especially on the LWR. This change can be attributed to the previous and circadian rhythm sleep disorders than malnutrition or dehydratation.

 

GZMB Antibody
CSB-PA272248-100ul	Cusabio	100ul	EUR 379.2
Description: A polyclonal antibody against GZMB. Recognizes GZMB from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:3000, IHC:1:50-1:100

GZMB Antibody
1-CSB-PA108047	Cusabio	Ask for price Ask for price	100ul 50ul
Description: A polyclonal antibody against GZMB. Recognizes GZMB from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:50-1:200

GZMB Antibody
ABD7012	Nova Lifetech	100ug	EUR 325

GZMB Antibody
KAA346M03F03C-100ug	Absea Biotechnology	100 ug	EUR 320
Description: Monoclonal Antibody

GZMB Antibody
KAA346M03F03C-1mg	Absea Biotechnology	1 mg	EUR 1600
Description: Monoclonal Antibody

GZMB Antibody
KAA346M03F03C-50ug	Absea Biotechnology	50 ug	EUR 224
Description: Monoclonal Antibody

GZMB Antibody
MBS7136741-005mL	MyBiosource	0.05mL	EUR 220

GZMB Antibody
MBS7136741-01mL	MyBiosource	0.1mL	EUR 300

GZMB Antibody
MBS7136741-5x01mL	MyBiosource	5x0.1mL	EUR 1350

GZMB Antibody
MBS7132128-01mL	MyBiosource	0.1mL	EUR 270

GZMB Antibody
MBS7132128-5x01mL	MyBiosource	5x0.1mL	EUR 1200

GZMB Antibody
MBS7123752-005mL	MyBiosource	0.05mL	EUR 190

GZMB Antibody
MBS7123752-01mL	MyBiosource	0.1mL	EUR 270

GZMB Antibody
MBS7123752-5x01mL	MyBiosource	5x0.1mL	EUR 1205

GZMB Antibody
MBS7123753-005mL	MyBiosource	0.05mL	EUR 190

GZMB Antibody
MBS7123753-01mL	MyBiosource	0.1mL	EUR 270

GZMB Antibody
MBS7123753-5x01mL	MyBiosource	5x0.1mL	EUR 1205

GZMB Antibody
MBS9413077-005mL	MyBiosource	0.05mL	EUR 300

GZMB Antibody
MBS9413077-01mL	MyBiosource	0.1mL	EUR 390

GZMB Antibody
MBS9413077-5x01mL	MyBiosource	5x0.1mL	EUR 1610

GZMB Antibody
MBS8504223-01mg	MyBiosource	0.1mg	EUR 325

GZMB Antibody
MBS8504223-01mLAF405L	MyBiosource	0.1mL(AF405L)	EUR 565

GZMB Antibody
MBS8504223-01mLAF405S	MyBiosource	0.1mL(AF405S)	EUR 565

GZMB Antibody
MBS8504223-01mLAF610	MyBiosource	0.1mL(AF610)	EUR 565

GZMB Antibody
MBS8504223-01mLAF635	MyBiosource	0.1mL(AF635)	EUR 565

GZMB Antibody
MBS2518949-006mL	MyBiosource	0.06mL	EUR 190

GZMB Antibody
MBS2518949-012mL	MyBiosource	0.12mL	EUR 265

GZMB Antibody
MBS2518949-02mL	MyBiosource	0.2mL	EUR 415

GZMB Antibody
MBS2518949-5x02mL	MyBiosource	5x0.2mL	EUR 1835

GZMB Antibody
MBS9607665-01mL	MyBiosource	0.1mL	EUR 260

GZMB Antibody
MBS9607665-02mL	MyBiosource	0.2mL	EUR 305

GZMB Antibody
MBS9607665-5x02mL	MyBiosource	5x0.2mL	EUR 1220

anti- GZMB antibody
FNab03737	FN Test	100µg	EUR 702
Description: Antibody raised against GZMB

GZMB Antibody (C-term)
MBS9209305-008mL	MyBiosource	0.08mL	EUR 210

GZMB Antibody (C-term)
MBS9209305-04mL	MyBiosource	0.4mL	EUR 430

GZMB Antibody (C-term)
MBS9209305-5x04mL	MyBiosource	5x0.4mL	EUR 1910

GZMB Antibody (N-term)
MBS9212735-008mL	MyBiosource	0.08mL	EUR 210

GZMB Antibody (N-term)
MBS9212735-04mL	MyBiosource	0.4mL	EUR 430

GZMB Antibody (N-term)
MBS9212735-5x04mL	MyBiosource	5x0.4mL	EUR 1910

Anti-Human GZMB Antibody
MBS1569301-01mg	MyBiosource	0.1mg	EUR 405

Anti-Human GZMB Antibody
MBS1569301-5x01mg	MyBiosource	5x0.1mg	EUR 1520

Anti-Human GZMB Antibody
MBS1568472-01mg	MyBiosource	0.1mg	EUR 405

Anti-Human GZMB Antibody
MBS1568472-5x01mg	MyBiosource	5x0.1mg	EUR 1520

GZMB / GZMH Antibody
20-abx329145	Abbexa	Ask for price Ask for price	100 ug 50 ug

GZMB/GZMH Antibody
1-CSB-PA009072	Cusabio	Ask for price Ask for price	100ug 50ug
Description: A polyclonal antibody against GZMB/GZMH. Recognizes GZMB/GZMH from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/5000

GZMB / GZMH Antibody
abx329145-100l	Abbexa	100 µl	EUR 187.5

GZMB/GZMH Antibody
MBS7118337-005mg	MyBiosource	0.05mg	EUR 150

GZMB/GZMH Antibody
MBS7118337-01mg	MyBiosource	0.1mg	EUR 190

GZMB/GZMH Antibody
MBS7118337-5x01mg	MyBiosource	5x0.1mg	EUR 845

Granzyme B (GZMB) Antibody
20-abx109837	Abbexa	Ask for price Ask for price Ask for price Ask for price Ask for price	100 ug 1 mg 200 ug 20 ug 50 ug

Granzyme B (GZMB) Antibody
20-abx112844	Abbexa	Ask for price Ask for price	150 ul 50 ul

Granzyme B (GZMB) Antibody
20-abx100561	Abbexa	Ask for price Ask for price Ask for price Ask for price Ask for price	100 ug 10 ug 1 mg 200 ug 50 ug

Granzyme B (GZMB) Antibody
20-abx128920	Abbexa	Ask for price Ask for price Ask for price Ask for price Ask for price	100 ug 10 ug 1 mg 200 ug 50 ug

Granzyme B (GZMB) Antibody
abx139484-01mg	Abbexa	0.1 mg	EUR 493.2

Granzyme B (GZMB) Antibody
20-abx013099	Abbexa	Ask for price Ask for price Ask for price Ask for price Ask for price	100 ug 10 ug 200 ug 300 µg 5 ug

Granzyme B (GZMB) Antibody
20-abx001994	Abbexa	Ask for price Ask for price Ask for price Ask for price	100 ul 200 ul 20 ul 50 ul

Granzyme B (GZMB) Antibody
20-abx210520	Abbexa	Ask for price Ask for price	100 ul 50 ul

Granzyme B (GZMB) Antibody
20-abx210840	Abbexa	Ask for price Ask for price	100 ul 50 ul

Granzyme B (GZMB) Antibody
abx233737-100ug	Abbexa	100 ug	EUR 661.2

Granzyme B (GZMB) Antibody
20-abx225208	Abbexa	Ask for price Ask for price Ask for price	100 ul 200 ul 50 ul

Granzyme B (GZMB) Antibody
20-abx172667	Abbexa	Ask for price Ask for price Ask for price Ask for price Ask for price	100 ug 1 mg 200 ug 20 ug 50 ug

Granzyme B (GZMB) Antibody
20-abx172668	Abbexa	Ask for price Ask for price	1 mg 200 ug

Granzyme B (GZMB) Antibody
20-abx176702	Abbexa	Ask for price Ask for price	1 mg 200 ug

Granzyme B (GZMB) Antibody
20-abx176703	Abbexa	Ask for price Ask for price	1 mg 200 ug

Granzyme B (GZMB) Antibody
abx332436-100ul	Abbexa	100 ul	EUR 510

GZMB Antibody / Granzyme B
F54859-0.08ML	NSJ Bioreagents	0.08 ml	EUR 140.25
Description: Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the remarkable ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'nonself' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. The protein is crucial for the rapid induction of target cell apoptosis by CTL in cell-mediated immune response.

GZMB Antibody / Granzyme B
F54859-0.4ML	NSJ Bioreagents	0.4 ml	EUR 322.15
Description: Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the remarkable ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'nonself' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. The protein is crucial for the rapid induction of target cell apoptosis by CTL in cell-mediated immune response.

Granzyme B (GZMB) Antibody
abx210520-100l	Abbexa	100 µl	EUR 350

Granzyme B (GZMB) Antibody
abx210520-50l	Abbexa	50 µl	EUR 250

Granzyme B (GZMB) Antibody
abx172667-1ml	Abbexa	1 ml	EUR 262.5

Granzyme B (GZMB) Antibody
abx210840-100l	Abbexa	100 µl	EUR 350

Granzyme B (GZMB) Antibody
abx210840-50l	Abbexa	50 µl	EUR 250

Granzyme B (GZMB) Antibody
abx128920-100l	Abbexa	100 µl	EUR 250

Granzyme B (GZMB) Antibody
abx128920-1ml	Abbexa	1 ml	EUR 675

Granzyme B (GZMB) Antibody
abx128920-200l	Abbexa	200 µl	EUR 312.5

Granzyme B (GZMB) Antibody
abx112844-100l	Abbexa	100 µl	EUR 612.5

Granzyme B (GZMB) Antibody
abx139484-100l	Abbexa	100 µl	EUR 337.5

Granzyme B (GZMB) Antibody
abx139484-500l	Abbexa	500 µl	Ask for price

Granzyme B (GZMB) Antibody
abx233737-100g	Abbexa	100 µg	EUR 350

Granzyme B (GZMB) Antibody
abx402403-100g	Abbexa	100 µg	EUR 287.5

Granzyme B (GZMB) Antibody
abx013099-100g	Abbexa	100 µg	EUR 237.5

Granzyme B (GZMB) Antibody
abx013099-10g	Abbexa	10 µg	EUR 43.75

Granzyme B (GZMB) Antibody
abx013099-200g	Abbexa	200 µg	EUR 312.5

Granzyme B (GZMB) Antibody
abx001994-100l	Abbexa	100 µl	EUR 400

Granzyme B (GZMB) Antibody
abx001994-20l	Abbexa	20 µl	EUR 175

Granzyme B (GZMB) Antibody
abx001994-50l	Abbexa	50 µl	EUR 275

Granzyme B (GZMB) Antibody
abx100561-100l	Abbexa	100 µl	EUR 262.5

Granzyme B (GZMB) Antibody
abx100561-1ml	Abbexa	1 ml	EUR 687.5

Granzyme B (GZMB) Antibody
abx100561-200l	Abbexa	200 µl	EUR 325

Granzyme B (GZMB) Antibody
abx109837-100l	Abbexa	100 µl	EUR 162.5

GZMB Antibody, HRP conjugated
1-CSB-PA010082LB01HU	Cusabio	Ask for price Ask for price	100ug 50ug
Description: A polyclonal antibody against GZMB. Recognizes GZMB from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

GZMB Antibody, FITC conjugated
1-CSB-PA010082LC01HU	Cusabio	Ask for price Ask for price	100ug 50ug
Description: A polyclonal antibody against GZMB. Recognizes GZMB from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

OAAN00893-50UL - GZMB Antibody
OAAN00893-50UL	Aviva Systems Biology	50ul	EUR 149

GZMB Antibody, Biotin conjugated
1-CSB-PA010082LD01HU	Cusabio	Ask for price Ask for price	100ug 50ug
Description: A polyclonal antibody against GZMB. Recognizes GZMB from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA

OAAN00893-100UL - GZMB Antibody
OAAN00893-100UL	Aviva Systems Biology	100ul	EUR 249

OAAN00893-200UL - GZMB Antibody
OAAN00893-200UL	Aviva Systems Biology	200ul	EUR 389

OAAJ01774-100UL - GZMB Antibody
OAAJ01774-100UL	Aviva Systems Biology	100ul	EUR 319

OAAF01817-100UG - GZMB Antibody
OAAF01817-100UG	Aviva Systems Biology	100ug	EUR 329

OAAJ07486-100UL - GZMB Antibody
OAAJ07486-100UL	Aviva Systems Biology	100uL	EUR 319

OASA00733-100UG - GZMB Antibody
OASA00733-100UG	Aviva Systems Biology	0.1mg	EUR 309

OASA02840-100UG - GZMB Antibody
OASA02840-100UG	Aviva Systems Biology	0.1mg	EUR 309

OAEE00403-100UG - GZMB Antibody
OAEE00403-100UG	Aviva Systems Biology	0.1mg	EUR 239

GZMB Monoclonal Antibody
E10-31969	EnoGene	100μg/100μl	EUR 225
Description: Available in various conjugation types.

GZMB Conjugated Antibody
C32711	SAB	100ul	EUR 476.4

GZMB Polyclonal Antibody
A55359	EpiGentek	Ask for price Ask for price Ask for price Ask for price	100 µg 20 ul 50 ul 100 ul

GZMB Polyclonal Antibody
A71559	EpiGentek	50 μl	EUR 408

GZMB Polyclonal Antibody
E-AB-60730-120uL	Elabscience Biotech	120uL	EUR 320
Description: Unconjugated

GZMB Polyclonal Antibody
E-AB-60730-200uL	Elabscience Biotech	200uL	EUR 530
Description: Unconjugated

GZMB Polyclonal Antibody
E-AB-60730-60uL	Elabscience Biotech	60uL	EUR 200
Description: Unconjugated

GZMB Polyclonal Antibody
E-AB-60730-each	Elabscience Biotech	each	Ask for price
Description: Unconjugated

GZMB Polyclonal Antibody
MBS9126731-002mL	MyBiosource	0.02mL	EUR 200

GZMB Polyclonal Antibody
MBS9126731-005mL	MyBiosource	0.05mL	EUR 255

GZMB Polyclonal Antibody
MBS9126731-01mL	MyBiosource	0.1mL	EUR 345

GZMB Polyclonal Antibody
MBS9126731-02mL	MyBiosource	0.2mL	EUR 545

GZMB Polyclonal Antibody
MBS9126731-5x02mL	MyBiosource	5x0.2mL	EUR 2265

GZMB Polyclonal Antibody
MBS2521358-002mL	MyBiosource	0.02mL	EUR 140

GZMB Polyclonal Antibody
MBS2521358-006mL	MyBiosource	0.06mL	EUR 180

GZMB Polyclonal Antibody
MBS2521358-012mL	MyBiosource	0.12mL	EUR 260

GZMB Polyclonal Antibody
MBS2521358-02mL	MyBiosource	0.2mL	EUR 405

GZMB Polyclonal Antibody
MBS2525619-002mL	MyBiosource	0.02mL	EUR 135

GZMB Polyclonal Antibody
MBS2525619-006mL	MyBiosource	0.06mL	EUR 180

GZMB Polyclonal Antibody
MBS2525619-012mL	MyBiosource	0.12mL	EUR 255

GZMB Polyclonal Antibody
MBS2525619-02mL	MyBiosource	0.2mL	EUR 400

GZMB Polyclonal Antibody
MBS2525619-5x02mL	MyBiosource	5x0.2mL	EUR 1715

GZMB Conjugated Antibody
MBS9443809-01mLAF350	MyBiosource	0.1mL(AF350)	EUR 480

GZMB Conjugated Antibody
MBS9443809-01mLAF405	MyBiosource	0.1mL(AF405)	EUR 480

GZMB Conjugated Antibody
MBS9443809-01mLAF488	MyBiosource	0.1mL(AF488)	EUR 480

GZMB Conjugated Antibody
MBS9443809-01mLAF555	MyBiosource	0.1mL(AF555)	EUR 480

GZMB Conjugated Antibody
MBS9443809-01mLBiotin	MyBiosource	0.1mL(Biotin)	EUR 480

GZMB Polyclonal Antibody
RD82685A-120uL	Reddot Biotech	120μL	EUR 360
Description: Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the remarkable ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'nonself' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. The protein encoded by this gene is crucial for the rapid induction of target cell apoptosis by CTL in cell-mediated immune response.

GZMB Polyclonal Antibody
RD82685A-200uL	Reddot Biotech	200μL	EUR 630
Description: Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the remarkable ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'nonself' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. The protein encoded by this gene is crucial for the rapid induction of target cell apoptosis by CTL in cell-mediated immune response.

GZMB Polyclonal Antibody
RD82685A-60uL	Reddot Biotech	60μL	EUR 204
Description: Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the remarkable ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'nonself' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. The protein encoded by this gene is crucial for the rapid induction of target cell apoptosis by CTL in cell-mediated immune response.

Granzyme B (GZMB) Antibody (PE)
abx201109-100tests	Abbexa	100 tests	EUR 710.4

Granzyme B (GZMB) Antibody (HRP)
20-abx108314	Abbexa	Ask for price Ask for price Ask for price Ask for price Ask for price	100 ug 1 mg 200 ug 20 ug 50 ug

Granzyme B (GZMB) Antibody (HRP)
abx108314-100g	Abbexa	100 µg	EUR 362.5

Granzyme B (GZMB) Antibody (HRP)
abx108314-20g	Abbexa	20 µg	EUR 162.5

Granzyme B (GZMB) Antibody (HRP)
abx108314-50g	Abbexa	50 µg	EUR 250

Anti-Human GZMB Antibody (Fv02)
MBS1564216-01mg	MyBiosource	0.1mg	EUR 405

Anti-Human GZMB Antibody (Fv02)
MBS1564216-5x01mg	MyBiosource	5x0.1mg	EUR 1520

Granzyme B (GZMB) Antibody (FITC)
20-abx106894	Abbexa	Ask for price Ask for price Ask for price Ask for price Ask for price	100 ug 1 mg 200 ug 20 ug 50 ug

Granzyme B (GZMB) Antibody (FITC)
abx106894-100g	Abbexa	100 µg	EUR 362.5

Granzyme B (GZMB) Antibody (FITC)
abx106894-20g	Abbexa	20 µg	EUR 162.5

Granzyme B (GZMB) Antibody (FITC)
abx106894-50g	Abbexa	50 µg	EUR 250

Anti-Granzyme B/Gzmb Antibody
A00353-1	BosterBio	100ug/vial	EUR 352.8